What impact will the 1 October PBS cuts have on the 20 most commonly prescribed medicines?
Pharmacy is gearing up for the 1 October round of PBS price cuts.
As recorded yesterday in AJP, more than 2000 medicine brands will be reduced in price for non-concessional patients in this wave of cuts.
The top 20 most prescribed medicines on the PBS will all experience some degree of price cuts from 1 October 2016.
The savings for these medicines may vary depending on a number of factors such as formulation and strength, brand, the concessional status of the patient and any discretionary fees added or discounting by the pharmacist.
Number of non-concessional patients benefiting
$ savings per script
% savings per script
|Levonorgestrel with ethinyloestradiol||>679000||Up to $0.85||4.65%|
|Rosuvastatin||>449000||Up to $4.63||14.23%|
|Atorvastatin||>395000||Up to $2.28||12.58%|
|Pantoprazole||>376000||Up to $0.45||3.20%|
|Metformin||>319000||Up to $0.54||3.42%|
|Perindopril||>285000||Up to $1.08||6.41%|
|Escitalopram||>285000||Up to $0.41||3.04%|
|Celecoxib||>270000||Up to $1.48||6.68%|
|Rabeprazole||>165000||Up to $1.45||9.14%|
|Irbesartan||>156000||Up to $1.89||11.41%|
|Telmisartan||>152000||Up to $2.62||12.50%|
|Venlafaxine||>137000||Up to $2.01||11.36%|
|Candesartan||>130000||Up to $1.50||7.85%|
|Ramipril||>130000||Up to $0.54||3.65%|
|Irbesartan with hydrochlorothiazide||>100000||Up to $3.85||20.14%|
|Citalopram||>100000||Up to $0.44||3.27%|
|Perindopril with amlodipine||>95000||Up to $1.08||6.02%|
|Duloxetine||>86000||Up to $2.22||11.17%|
|Simvastatin||>82000||Up to $0.69||4.60%|
|Telmisartan with hydrochlorothiazide||>65000||Up to $2.61||11.62%|